FDA Oncology Center of Excellence during COVID-19

What The Viewpoint Says: This Viewpoint discusses initiatives of the U.S. Food and Drug Administration’s Oncology Center of Excellence to address COVID-19-related challenges faced by patients with cancer and the health care professionals who provide cancer treatment.

Authors: Jennifer J. Gao, M.D., of the Oncology Center of Excellence at the FDA in Silver Spring, Maryland, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamaoncol.2020.6783)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6783?guestAccessKey=f0b0978e-0660-492a-baaa-08369b85bc7f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122320

Source link

#FDA #Oncology #Center #Excellence #COVID19